| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,273,397 |
|
|
|
Indirect Value
|
$265,218 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$23,538,615 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
SVP Fin, Dep CFO |
• – – |
2013-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
17,348 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2019-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,625 |
24,973 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,930 |
25,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,971 |
29,957 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,853 |
32,844 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2015-04-08 |
4 |
OE |
$272.70 |
$2,727,000 |
D/D |
10,000 |
15,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2015-08-05 |
4 |
OE |
$272.70 |
$1,090,800 |
D/D |
4,000 |
11,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-07 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-22 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-30 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-01 |
4 |
OE |
$272.70 |
$818,100 |
D/D |
3,000 |
10,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-12 |
4 |
OE |
$272.70 |
$136,350 |
D/D |
500 |
25,473 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-24 |
4 |
OE |
$272.70 |
$272,700 |
D/D |
1,000 |
25,973 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-25 |
4 |
OE |
$272.70 |
$272,700 |
D/D |
1,000 |
26,187 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-01 |
4 |
OE |
$272.70 |
$1,636,200 |
D/D |
6,000 |
26,888 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-02 |
4 |
OE |
$272.70 |
$818,100 |
D/D |
3,000 |
28,726 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-06 |
4 |
OE |
$272.70 |
$818,100 |
D/D |
3,000 |
27,373 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-09 |
4 |
OE |
$272.70 |
$954,450 |
D/D |
3,500 |
27,873 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-14 |
4 |
OE |
$272.70 |
$954,450 |
D/D |
3,500 |
27,873 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-16 |
4 |
OE |
$272.70 |
$1,090,800 |
D/D |
4,000 |
28,373 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-17 |
4 |
OE |
$272.70 |
$3,408,750 |
D/D |
12,500 |
36,873 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-06-08 |
4 |
OE |
$272.70 |
$4,226,850 |
D/D |
15,500 |
29,730 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-06-10 |
4 |
OE |
$272.70 |
$954,450 |
D/D |
3,500 |
27,873 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-03-27 |
4 |
OE |
$378.98 |
$1,442,476 |
D/D |
3,800 |
35,316 |
0 |
- |
|
158 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
